These findings indicate that the TRPM7 of ME/CFS patients is structurally or functionally resistant to desensitisation and may reflect a compensatory response to dysregulated cellular signalling or metabolic processes in ME/CFS. Here, TRPM7 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.